Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vasa DenticityNSE:DENTALKART -2.80%80 Debt-to-EBITDA is 0.01 as of Mar. 2026, which is 96% below its 10-year median of 0.27. GuruFocus rates NSE:DENTALKART with a GF Score™ of 80/100 and a GF Value™ of ₹877.39 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 90 Medical Distribution companies, Vasa Denticity ranks better than 98.89% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Vasa Denticity's Debt-to-EBITDA or its related term are showing as below:
NSE:DENTALKART'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0 Med: 0.27 Max: 3.35
Current: 0.01
During the past 6 years, the highest Debt-to-EBITDA Ratio of Vasa Denticity was 3.35. The lowest was 0.00. And the median was 0.27.
NSE:DENTALKART's Debt-to-EBITDA is ranked better than 98.89% of 90
companies
in the Medical Distribution industry
Industry Median: 2.45
vs NSE:DENTALKART: 0.01
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Vasa Denticity Debt-to-EBITDA Related Terms
Vasa Denticity Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Vasa Denticity's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:DENTALKART vs MCK, COR, CAH: Debt-to-EBITDA Comparison
For the Medical Distribution subindustry, Vasa Denticity's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vasa Denticity Debt-to-EBITDA vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Vasa Denticity's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Vasa Denticity's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is two times the quarterly (Mar. 2026) EBITDA data.
Vasa Denticity (NSE:DENTALKART) has a Debt-to-EBITDA of 0.01 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Vasa Denticity. This is 96% below median its historical median of 0.27. According to the industry distribution chart, Vasa Denticity ranks #1 out of 90 companies in the Medical Distribution industry, placing it in the top 1.1%.
Is Vasa Denticity's Debt-to-EBITDA too high?
Vasa Denticity's current Debt-to-EBITDA of 0.01 is 96% below median its 10-year median of 0.27. The Medical Distribution industry median Debt-to-EBITDA is 2.45. Vasa Denticity's value of 0.01 is 99.6% below this industry median. Based on the distribution chart, Vasa Denticity ranks #1 out of 90 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Vasa Denticity has a GF Score™ of 80/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vasa Denticity's Debt-to-EBITDA compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Vasa Denticity ranks #1 out of 90 companies for Debt-to-EBITDA. This places Vasa Denticity in the top 1% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 2.45. Vasa Denticity's value of 0.01 is 99.6% below this benchmark. While the company's 10-year median is 0.27 vs. the industry median of 2.45, Vasa Denticity has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Distribution company?
The median Debt-to-EBITDA among Medical Distribution companies is 2.45, based on 90 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vasa Denticity's current Debt-to-EBITDA of 0.01 is 99.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Vasa Denticity. For the Medical Distribution industry, the median Debt-to-EBITDA is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vasa Denticity's current Debt-to-EBITDA is 0.01, which is 96% below median its own 10-year median of 0.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vasa Denticity stock overvalued right now?
Based on GuruFocus' analysis, Vasa Denticity (NSE:DENTALKART) is currently considered Possible Value Trap. The stock's GF Value™ is ₹877.39, compared to a current price of ₹413.05 — trading 52.9% below its estimated fair value. The current Debt-to-EBITDA is 0.01, which is 96% below median its 10-year median of 0.27 and 99.6% below the Medical Distribution industry median of 2.45. Vasa Denticity's overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Vasa Denticity (NSE:DENTALKART), the current Debt-to-EBITDA is 0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vasa Denticity (NSE:DENTALKART) Overvalued in 2026?
Based on GuruFocus' analysis, Vasa Denticity stock appears to be undervalued.
The current stock price of ₹413.05 is trading 52.9% below its estimated GF Value™ of ₹877.39.
GuruFocus considers Vasa Denticity to be Possible Value Trap.
Key valuation signals for NSE:DENTALKART:
Debt-to-EBITDA: 0.01 (96% below median its 10-year median of 0.27)
GF Value™: ₹877.39 vs. price of ₹413.05 (52.9% below fair value)
Industry Position: 99.6% below the Medical Distribution median (#1 of 90)
No single metric tells the full story. See the NSE:DENTALKART stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vasa Denticity Ltd is engaged in marketing and distributing a comprehensive portfolio of dental products, including consumables, instruments, equipment, and accessories for diagnosing, treating, and preventing dental conditions, as well as improving the aesthetics of the human smile through the online portal Dentalkart.com. The company's products include instruments, disinfectant tools, sterilizing equipment, impression materials, temporary materials for tooth filling, and others.
80GF Score
Get the complete analysis for NSE:DENTALKART
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:DENTALKART has been successfully added to your 
